Skip to main content
Journal ArticleOPEN ACCESS

Venetoclax and Azacitidine in the Treatment of NPM1 -Mutated Donor Cell–Derived Leukemia in a Patient With Fanconi Anemia: Case Report and Literature Review

  • Ma J
  • Morimoto K
  • Pulsipher M
  • et al.
JCO Precision Oncology (2023) (7)
DOI: 10.1200/po.22.00693
2Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Deep remission with #venetoclax and #azacitidine in a child with Fanconi anemia and donor cell leukemia

Cite

CITATION STYLE

APA

Ma, J., Morimoto, K., Pulsipher, M. A., & Parekh, C. (2023). Venetoclax and Azacitidine in the Treatment of NPM1 -Mutated Donor Cell–Derived Leukemia in a Patient With Fanconi Anemia: Case Report and Literature Review. JCO Precision Oncology, (7). https://doi.org/10.1200/po.22.00693

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free